<p>Efficacy and Safety of the CFTR Potentiator Icenticaftor (QBW251) in COPD: Results from a Phase 2 Randomized Trial</p>-Reference-Cited by-同舟云学术

Efficacy and Safety of the CFTR Potentiator Icenticaftor (QBW251) in COPD: Results from a Phase 2 Randomized Trial

Published:2020-10 Issue: Volume:Volume 15 Page:2399-2409
ISSN:1178-2005
Container-title:International Journal of Chronic Obstructive Pulmonary Disease
language:en
Short-container-title:COPD

Author:

Rowe Steven M,Jones Ieuan,Dransfield Mark T,Haque Nazmul,Gleason Stephen,Hayes Katy A,Kulmatycki Kenneth,Yates Denise P^ORCID,Danahay Henry,Gosling Martin,Rowlands David J,Grant Sarah S

Publisher

Informa UK Limited

Subject

Public Health, Environmental and Occupational Health,Health Policy,Pulmonary and Respiratory Medicine,General Medicine

Reference45 articles.

1. Global initiative for chronic obstructive lung disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (2018 Report); 2018.

2. World health organization. Chronic Obstructive Pulmonary Disease (Copd); 2016.

3. The Nature of Small-Airway Obstruction in Chronic Obstructive Pulmonary Disease

4. Small Airway Mucous Metaplasia and Inflammation in Chronic Obstructive Pulmonary Disease

5. Goblet Cell Hyperplasia and Epithelial Inflammation in Peripheral Airways of Smokers with Both Symptoms of Chronic Bronchitis and Chronic Airflow Limitation

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cystic Fibrosis: Understanding Cystic Fibrosis Transmembrane Regulator Mutation Classification and Modulator Therapies;Advances in Respiratory Medicine;2024-07-20

2. Comparison of a novel potentiator of CFTR channel activity to ivacaftor in ameliorating mucostasis caused by cigarette smoke in primary human bronchial airway epithelial cells;Respiratory Research;2024-07-10

3. An experimentally validated approach to automated biological evidence generation in drug discovery using knowledge graphs;Nature Communications;2024-07-08

4. Real-time breath metabolomics to assess early response to CFTR modulators in adults with cystic fibrosis: an open-label proof-of-concept study;2024-05-31

5. Comparison of a novel potentiator of CFTR channel activity to ivacaftor in ameliorating mucostasis caused by cigarette smoke in primary human bronchial airway epithelial cells;2024-03-04